Medication info
Telmisartan Tablets 40 mg (Telmisartan)

Telmisartan Tablets 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Vivozon Pharmaceutical Co., Ltd.
Appearance
White oval-shaped tablets
Packaging
PTP - 30 tablets/box [(10 tablets/Alu-Alu × 3)], PE bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 201902498 · Approved 2019.04.23 · Insurance code 658204220

Summary

Main use
Treatment of essential hypertension and prevention of cardiovascular diseases (such as myocardial infarction and stroke)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken regardless of meals. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: Administration of 80 mg of this medicine orally once daily with water is recommended, and it may be taken regardless of meals. The risk-reducing effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Vivozon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and prevention of cardiovascular diseases (such as myocardial infarction and stroke)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinical evidence of organ damage in high-risk diabetes.
View approved original text

This medication is primarily used in patients with essential hypertension and effectively controls blood pressure. It is also developed for high-risk cardiovascular disease patients over 55 years old who cannot take ACE inhibitors. It helps reduce the risk of myocardial infarction, stroke, and death due to cardiovascular disease in these patients. It is used to manage hypertension and lower the possibility of severe complications from cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken regardless of meals. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: Administration of 80 mg of this medicine orally once daily with water is recommended, and it may be taken regardless of meals. The risk-reducing effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This drug can cause serious harm to the fetus and newborn, especially during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Those with allergies to this medication or its components should not use it. Patients with severely impaired liver function or problems with bile secretion should not take this drug. Patients with hereditary angioedema or a history of angioedema should not use this medication. In diabetic patients with severely impaired kidney function, the combination of this drug with certain medications is prohibited. Patients with genetic metabolic issues such as lactose intolerance should not take this drug. Elderly patients, those with hyperkalemia, and patients with weak liver function should be cautious and may need dosage adjustments. Patients with heart valve disease or cerebrovascular disorders should watch for excessively low blood pressure. Patients with kidney-related issues or severely impaired kidney function should be cautious, as taking this drug may worsen kidney function. When used with other antihypertensives, this drug may increase blood pressure-lowering effects, so caution is needed. Serum potassium levels may increase, so patients at risk of hyperkalemia should have regular blood tests. This drug may cause dizziness or fainting during driving or operating machinery, so caution is necessary. Pregnant or breastfeeding women should not take this drug, as it may pose risks to the fetus, especially during pregnancy. Safety and efficacy in pediatric patients have not been established, and it is advisable not to use in patients under 18 years of age. In the event of overdose, symptoms such as hypotension, arrhythmia, dizziness, and kidney dysfunction may occur, requiring immediate medical attention. This medication should be stored out of reach of children and it is recommended to open the packaging just before use. During treatment, liver function, kidney function, electrolyte levels, etc., should be regularly monitored, and any abnormal symptoms should be immediately reported to a healthcare professional.

Side effects

  • Upper respiratory infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 113 more
  • anaphylactic reactions
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • abnormal liver function
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • elevated serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • fasting
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • angioedema
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • hypotension
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • respiratory distress
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • pneumonia
  • rhabdomyolysis
  • myalgia
  • increased creatine kinase
  • elevated serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • insufficient effect
  • headache
  • dizziness
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy.

Appearance and packaging

Appearance

White oval-shaped tablets

Package unit

PTP - 30 tablets/box [(10 tablets/Alu-Alu × 3)], PE bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.